SYK logo

SYK

Stryker CorporationNYSEHealthcare
$331.54+0.65%OpenMarket Cap: $126.88B

As of 2026-04-06

Valuation

View Details

P/E (TTM)

39.09

PEG

4.62

P/B

5.66

P/S

5.05

EV/EBITDA

24.66

DCF Value

$318.10

FCF Yield

3.4%

Div Yield

1.0%

Margins & Returns

Gross Margin

63.5%

Operating Margin

22.4%

Net Margin

12.9%

ROE

15.0%

ROA

14.2%

ROIC

10.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$7.17B$849.0M$2.20
FY 2025$25.12B$3.25B$8.40
Q3 2025$6.06B$859.0M$2.22
Q2 2025$6.02B$884.0M$2.29

Analyst Ratings

View All
UBSNeutral
2026-03-17
NeedhamBuy
2026-01-30
BTIGBuy
2026-01-30
BernsteinOutperform
2026-01-09
CitizensMarket Outperform
2025-12-19

Trading Activity

Insider Trades

View All
Stiles Spencer Sofficer: President and COO
SellTue Mar 24
Stiles Spencer Sofficer: President and COO
SellTue Mar 24
Pierce James Andrewofficer: Group President
SellTue Mar 24
Pierce James Andrewofficer: Group President
SellTue Mar 24
Menon Vijuofficer: Group President
SellTue Mar 24

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NYSE

Beta

0.93

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Peers